Authors
Latest:
Roundtable: The ob/gyn and legal liability: condition critical, Part 1It's hard to imagine a more serious crisis than the current legal liability debacle facing American ob/gyns. Dr. Charles Lockwood has gathered the profession's thought leaders to help analyze its complexities and discuss possible solutions.
Latest:
Roundtable: The ob/gyn and legal liability: condition critical, Part 1It's hard to imagine a more serious crisis than the current legal liability debacle facing American ob/gyns. Dr. Charles Lockwood has gathered the profession's thought leaders to help analyze its complexities and discuss possible solutions.
Latest:
Roundtable: The ob/gyn and legal liability: condition critical, Part 1It's hard to imagine a more serious crisis than the current legal liability debacle facing American ob/gyns. Dr. Charles Lockwood has gathered the profession's thought leaders to help analyze its complexities and discuss possible solutions.
Latest:
Was this prolapse properly managed?In a case with multiple defendants, coordinating defenses should be the primary objective for trial.
Latest:
Improving survival in twin-twin transfusion syndromeAlthough serial amnioreduction is still widely used to treat this dangerous condition, a recent randomized trial found that when compared to amnioreduction at 15 to 26 weeks, overall perinatal survival is higher with laser ablation, which tries to reverse the disease process.
Latest:
Ob/gyn complications of celiac diseaseHalf of all adults with this autoimmune disorder don't have the classic GI symptoms, which include bloating and diarrhea. So should you screen women with otherwise unexplained infertility for it? Other ob/gyn complications in women with celiac disease include miscarriage, iron deficiency anemia, and IUGR.
Latest:
Meet the Board: Sarah J. Kilpatrick, MD, PhDIntroducing Contemporary OB/GYN® Editorial Advisory Board member, Sarah J. Kilpatrick, MD, PhD.
Latest:
Podcast: Discussing the ARRIVE trial resultsDr. Charles J. Lockwood sits down with Linda Marie Wetzel, Executive Editor for Contemporary OB/GYN, to discuss the results of the ARRIVE study and what these findings mean for ob/gyns and their patients.
Latest:
What’s new in biomarker testing for ovarian cancerThree tests are now FDA-approved for triaging pelvic masses in asymptomatic women.
Latest:
Informed consent and the mentally challenged patientTrue consent requires an understanding of decisions-and their consequences. With sensitivity, it's possible to respect a patient's autonomy while acknowledging limitations in her mental state.
Latest:
NASPAG 2021: Hillard’s HighlightsContemporary OB/GYN® Editorial Board Member Paula J. Adams Hillard, MD, reports on the Annual Clinical & Research Meeting (ACRM) of the North American Society for Pediatric and Adolescent Gynecology (NASPAG), which was held virtually on March 18 to 21. The meeting drew gynecologists who specialize in pediatric and adolescent gynecology (PAG) and pediatricians who practice adolescent medicine, nursing and advanced practice nursing professionals, and various other clinicians who take care of girls and adolescents with gynecologic problems.
Latest:
Point-of-care diagnosis of STIs in womenBypassing the lab and rapidly diagnosing patients right then and there has its limitations, but benefits of POC testing go beyond delivering timelier STI treatment. Complications should be fewer-and you'll no longer be treating noninfected women.
Latest:
Aromatase inhibitors: The next wave in treatment of endometriosis?Blocking the activity of aromatase may be the key to controlling the often-intractable pain of endometriosis. Here, pioneers in the use of aromatase inhibitors review use of the drugs in premenopausal and postmenopausal patients.
Latest:
Aromatase inhibitors: The next wave in treatment of endometriosis?Blocking the activity of aromatase may be the key to controlling the often-intractable pain of endometriosis. Here, pioneers in the use of aromatase inhibitors review use of the drugs in premenopausal and postmenopausal patients.
Latest:
Point-of-care diagnosis of STIs in womenBypassing the lab and rapidly diagnosing patients right then and there has its limitations, but benefits of POC testing go beyond delivering timelier STI treatment. Complications should be fewer-and you'll no longer be treating noninfected women.
Latest:
Does low blood pressure increase the risk of stillbirth?While most ob/gyns can recite a long list of risk factors for this lethal complication, mounting evidence suggests that maternal hypotension should be taken into account as well.
Latest:
Targeted bio weapons in the war against gynecologic cancersWill biological warfare revolutionize the battle against gynecologic cancers? Two experts share the latest molecular tactics using "special" agents. Lethal weapons like Herceptin can throw up some roadblocks, even when they can't always destroy a tumor.
Latest:
ERAS: Improved outcomes post-cesareanAn ob/gyn shares her experience with implementing enhanced recovery after surgery (ERAS) and its effect on patient care at her institution
Latest:
Taking aim at the top 3 patient safety errors in ob/gynWhat can you do right now in your daily practice to prevent the three most common-and potentially dangerous-types of medical errors?
Latest:
Alternatives to traditional surgery for fibroidsExperts provide an update on current and emerging drugs and procedures as an alternative to myomectomy for uterine leiomyomas.
Latest:
Transforming public health through vaccinationsFrom the eradication of smallpox to the COVID-19 pandemic, vaccines have revolutionized health care, but rising vaccine hesitancy now threatens progress, especially among pregnant women.
Latest:
Leveling with patients about the risks of ARTBe frank about the real and potential complications when counseling patients considering assisted reproductive technologies. The list includes the link between multiple gestations and preterm delivery, the possibility of ectopic pregnancies or malformations-and much more.
Latest:
Alternative approaches to overactive bladderAlthough traditional drugs work for most patients, potential side effects turn some patients off. Examining the evidence, two experts argue for trying approaches like magnetic and electrical stimulation, acupuncture, or Botox.
Latest:
Grand Rounds: Finding the best approach to dysmenorrheaCombining NSAIDs with a new way of administering a centuries-old "folk" remedy offers many women significant relief.
Latest:
Office-based hysteroscopy: getting started nowWhat's holding you back? Cost? Worries about managing pain or complications? An expert debunks common excuses for not doing more office-based procedures and explains why you need both U/S and diagnostic hysteroscopy-and the rewards you can reap from taking your practice in this direction.
Latest:
HBOC and Lynch syndrome testing: All in a day’s workOb/gyns have a responsibility and can no longer be passive in this genomic era.
Latest:
Distinguishing and treating PMS and PMDDWith as many as 9 out of 10 menstruating women reporting some premenstrual moody blues, what criteria do you use to differentiate mild PMS from severe PMS from premenstrual dysphoric disorder? And what treatments are effective?
Latest:
Ob/gyn complications of celiac diseaseHalf of all adults with this autoimmune disorder don't have the classic GI symptoms, which include bloating and diarrhea. So should you screen women with otherwise unexplained infertility for it? Other ob/gyn complications in women with celiac disease include miscarriage, iron deficiency anemia, and IUGR.
Latest:
Grand Rounds: A thorough approach to pelvic painWith a treatment algorithm that encourages gynecologists to think 'outside the box,' one expert focuses on approaches originally developed for neuropathic pain, irritable bowel syndrome, and low back pain.
